Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers from the University of Oxford have developed a new 3D-printing method to improve how laboratory-grown cells form living structures. Explained in Scientific Reports, the new method aims to change regenerative medicine by producing complex tissues and cartilage capable of supporting or repairing damaged areas in the body.
A new smartphone application could improve personalized care and outcomes, according to a study published in the American Journal of Geriatric Psychiatry. The new app combined medical and psychiatric self-management care directed at patients with serious mental illness to keep them engaged in their own care and improve outcomes.
Acuity Link, a technology company that assists hospitals and medical transport providers through automation of non-emergency transport bookings, officially announced the availability of their new cloud-based software Tuesday.
The number of counties at risk of having no insurer on their Affordable Care Act (ACA) exchange has fallen to just two, with Centene stepping in to cover potentially bare counties in Nevada.
Controlling lipid levels in patients with atherosclerotic cardiovascular disease (ASCVD) can be improved with oral-only lipid lowering treatments, according to new research. A simulation study showed that 99.3 percent of patients could achieve low-density lipid (LDL) levels below 70 mg/dL with maximal intensification.
Microfluidic “lab on a chip” devices and 3D printing are being paired together by researchers at Brigham Young University. The team wanted to improve the effectiveness of such devices, which can be less than 100 micrometers. A report from Lab on a Chip outlined how the technology can better identify disease biomarkers.
The number of patients on transplant lists far outweighs the number of available organs, but a new development in gene editing could change things. Researchers have created gene-edited piglets without viruses that can cause diseases in humans.
Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.